Kang Cheng - Concepedia

Author

Kang Cheng

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

Cheng K, Cheng, Kang, K Cheng, K. CHENG, K. Cheng, KANG CHENG, Kang Cheng, Kang Lun Cheng

104

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of Virginia Zhejiang University of Technology Arena Pharmaceuticals (United States)

About

Kang Cheng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	2K
2	Natural Sciences	15	17	588
3	Health Sciences	5	5	560
4	Public Health	2	2	99
5	Engineering	1	1	11

Kang Cheng

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Generation by Insulin of a Chemical Mediator That Controls Protein Phosphorylation and Dephosphorylation Joseph Larner, Gail Galasko, Kang Cheng, Science Muscle FunctionCyclic Adenosine MonophosphateInsulin SignalingMetabolic SyndromeSkeletal Muscle	1979	375
Antagonism of the prostaglandin D <sub>2</sub> receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans Kang Cheng, Tsuei-Ju Wu, Kenneth K. Wu, Proceedings of the National Academy of Sciences InflammationMolecular PharmacologySignal TransductionMolecular PhysiologyMedicine	2006	268
3-(1<i>H</i>-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui, Journal of Medicinal Chemistry No Vasodilatory ActivityHyperlipidemiaPharmacotherapyExperimental PharmacologyMolecular Pharmacology	2008	93
Cobalt(III)-Catalyzed Fast and Solvent-Free C–H Allylation of Indoles Using Mechanochemistry Xinpeng Jiang, Jinkang Chen, Weijie Zhu, The Journal of Organic Chemistry	2017	81
Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats Hong C. Shen, Fa‐Xiang Ding, Qiaolin Deng, Journal of Medicinal Chemistry Tricyclic AnaloguesMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	2009	78
Measurement of membrane potentials (ψ) of erythrocytes and white adipocytes by the accumulation of triphenylmethylphosphonium cation Kang Cheng, Howard C. Haspel, Mary Lou Vallano, The Journal of Membrane Biology Triphenylmethylphosphonium CationMembrane PotentialsBiochemistryMembrane TransportPhysiology	1980	74
Studies on the Insulin Mediator: II. Separation of Two Antagonistic Biologically Active Materials from Fraction II Kang Cheng, Gail Galasko, Laura C. Huang, Diabetes	1980	64
Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate Hong C. Shen, Fa‐Xiang Ding, Subharekha Raghavan, Journal of Medicinal Chemistry Potent Niacin ReceptorExcellent Receptor ActivityPharmacotherapyExperimental PharmacologyMedicinal Chemistry	2010	57
Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist Robert J. DeVita, Darius D. Hollings, Mark T. Goulet, Bioorganic & Medicinal Chemistry Letters BiochemistryG Protein-coupled ReceptorMedicineFunctional SelectivityReceptor (Biochemistry)	1999	57
Caveolin-1 accelerates hypoxia-induced endothelial dysfunction in high-altitude cerebral edema Yan Xue, Xueting Wang, Baolan Wan, Cell Communication and Signaling	2022	57

Page 1